Background: Preoperative anemia and transfusion are associated with increased morbidity and mortality in cardiac surgery patients. It is unclear which of these factors plays the leading role in poor outcomes after cardiac surgery. The goal of this study was to analyze the influence of anemias of varying severity and intraoperative transfusion on long-term survival, and to characterize their interaction in cardiac surgery patients.
surgery has been reported for patients with Hb<12 g/dL 3, 4 ; however, the impact of severe preoperative anemia (Hb <10 g/dL) on short-and long-term survival after cardiac surgery remains unclear.
Preoperative and intraoperative strategies to treat anemia and avoid transfusion are recommended by national German and international guidelines, 5, 6 yet patients with preoperative anemia undergoing cardiac surgery are more likely to receive a transfusion than patients without preoperative anemia. 7, 8 Even though the most widely used treatment for preoperative anemia is transfusion of allogeneic packed red blood cells (RBCs), this treatment is controversial, given that blood transfusion has been associated with adverse outcomes after cardiac surgery. Receipt of transfusion has been identified as an important risk factor for 30-day and long-term all-cause mortality, [9] [10] [11] myocardial infarction, 9 and acute renal failure. 12 Moreover, treating anemia with transfusion is associated with prolonged stays in the intensive care unit (ICU) and the hospital, 10 as well as with significantly greater short-term mortality (<30 days) in patients with preoperative anemia compared with those without preoperative anemia 13 ; however, this association was shown only for mild anemia and short-term survival.
For that reason, the primary purpose of this work was to assess the degree to which the severity of anemia impacts long-term mortality after cardiac surgery. Furthermore, given that both preoperative anemia and its treatment (blood transfusion) impair outcomes after cardiac surgery and may confound the assessment of each risk factor, the secondary purpose was to weigh the risk of anemia and blood transfusion for 3-year survival after cardiac surgery.
METHODS

Data Source
This observational cohort study was conducted at Charit e-University Hospital in Berlin, Germany. After approval from the Federal Data Protection Officer and the hospital's Ethics Commission (Ethikkommission der Charit e-Universit€ atsmedizin Berlin; reference no. EA1/034/13), routine clinical data from all patients undergoing cardiac surgery between 2006 and 2011 were extracted from the 2 electronic patient data management systems (PDMSs) at our hospital (COPRA System; Sasbachwalden, Germany and SAP AG; Walldorf, Germany). Owing to its retrospective character, the need for informed patient consent was waived by the Ethics Commission. The time frame for this analysis was chosen to generate a representative substantial study population with minimal effects of changes in cardiac surgery procedures over time.
Patient Population
We included all patients aged 18 or older who underwent cardiac surgery during the study period. Patients without preoperative assessment of Hb or electronic documentation of intraoperative transfusion were excluded.
Patient age, sex, and body mass index (BMI); preexisting medical conditions; type and duration of surgery, with duration of cardiopulmonary bypass (CPB) as a marker of its complexity; and preoperative risk 14 ) were used to characterize the study population and to identify possible confounders. Preexisting medical conditions were derived from International Classification of Diseases, Tenth Revision coded diagnoses available from the PDMS. Renal dysfunction was defined as a preoperative serum creatinine level >1.7 mg/dL.
Definitions and End Points
Cardiac surgery. Cardiac surgery was defined as any documented procedure for a coronary artery bypass grafting (CABG), valve surgery or a combination of the 2, including both elective and emergency procedures. CPB and anesthesia management were performed according to the department's standard operating procedures. 17 After chest closure, the patient was transferred to the ICU while intubated and mechanically ventilated. Patients were extubated when hemodynamic stability was achieved (ie, heart rate of 80-100 bpm, mean arterial pressure of 65-85 mm Hg, central venous pressure of 8-12 mm Hg (at a positive end-expiratory pressure of 5 cm H 2 O), pulmonary artery occlusion pressure of 12-15 mm Hg, cardiac index of>2.5 L/min/m 2 , stroke volume index of >30 mL/m 2 , mixed venous oxygen saturation of>65), chest tube drainage was negligible (<100 mL/h) and lung function was sufficient (oxygen saturation in arterial blood !95%, with a fraction of inspired oxygen value 35%). 18 Hemodynamic optimization was maintained continuously according to German guidelines. 19 
Severity of Preoperative Anemia
Following the definition of the World Health Organization (WHO), female patients with a preoperative Hb level <12 g/dL and male patients with a preoperative Hb <13 g/dL were classified as anemic. 20 Further subclassification was done for mild anemia (females, Hb 10-12 g/dL; males, Hb 10-13 g/dL) and severe anemia (females and males, Hb 10 g/dL). Grouping was based on the last available Hb value measured before surgery.
Intraoperative Transfusion
Intraoperative transfusion was administered according to institutional standard operating procedures, 17, 18 which are based on national guidelines. 6 In these guidelines, an Hb of 6 g/dL (3.7 mmol/L) is defined as a threshold for RBC transfusion. In patients with a moderately reduced Hb of 6 to 8 g/dL (3.7 to 5.0 mmol/L), recommendations depend on individual risk factors and compensation capabilities. In the absence of respective preexisting medical conditions, such as coronary heart disease, heart failure, or cerebrovascular insufficiency, RBC transfusions are not recommended. 
Outcomes
The primary study endpoint was long-term survival. For this purpose, we defined a subpopulation of patients with an observation time of 3 years after surgery. This means that events (death) were registered only within 3 years after surgery, patients who were lost to follow-up (within 3 years) were censored, and patients who survived for>3 years were censored with the end of observation period (3 years after surgery). Data on long-term survival were acquired by consulting the local authorities in Berlin, Germany, after clearance from the Federal Data Safety Officer. In-hospital mortality, length of stay in the ICU, and length of stay in the hospital were defined as secondary endpoints.
Interaction of Severity of Preoperative Anemia and Intraoperative Transfusion
To account for interactions of preoperative anemia and RBC transfusion, an interaction term was defined out of both variables, resulting in 6 combinations of preoperative anemia of different severity and transfusion: no anemia/no transfusion, no anemia/transfusion, mild anemia/no transfusion, mild anemia/transfusion, severe anemia/no transfusion, and severe anemia/transfusion.
Statistical Analyses
Descriptive analyses and statistical testing were performed using R 3.0.1. 22 We considered a P value <.05 as significant. When normal distribution was ruled out using the Kolmogorov-Smirnov test, results are given as median and interquartile range (IQR); otherwise, they are given as mean AE standard deviation. Qualitative observations are characterized by frequency, in percentage. Statistical significance among groups was univariately analyzed using the exact nonparametric Kruskal-Wallis test and (pairwise) with the exact Mann-Whitney U test. The exact c 2 test was used for qualitative data. Survival was analyzed using Kaplan-Meier estimations and tested using the log-rank test between groups.
To accommodate a multivariate design, survival analyses were carried out using Cox regression analysis on the following preoperative variables: age; sex; BMI; type of surgery; duration of CPB; priority of surgery; age, serum creatinine level, and ejection fraction (ACEF) score 14 ; chronic obstructive pulmonary disease (COPD); coronary artery disease; diabetes mellitus; atrial fibrillation; peripheral vascular disease; left ventricular ejection fraction (LVEF) <35%; and preoperative renal insufficiency, reflected by preoperative serum creatinine >1.7 mg/dL. In addition, preoperative anemia and intraoperative transfusion were included as categorical variables in the analysis as potential confounders.
We investigated the association between the severity of preoperative anemia and intraoperative transfusion by repeating the foregoing regression model and replacing the 2 variables by an interaction term combining all combinations (see above). Furthermore, specific hazard ratios (HRs) for all combinations of anemia and transfusion were calculated to quantify their impact on survival. All tests are presented as explorative analyses, because no adjustments for multiple testing were made. The proportional hazards assumption was checked. Grambsch tests yielded a violation of the assumption, but log-minus-log plots revealed that the violation refers to the beginning of the observation period, in line with the widely acknowledged observation that deaths within a few months after surgery and deaths beyond 1 year after surgery are attributed to different causes and have different risk factors.
RESULTS
Patient Characteristics
Over the 6-year observation period, 5389 patients undergoing cardiac surgery were screened for eligibility ( Figure 1 ). We excluded 288 patients because of missing preoperative Hb values, and another 607 patients for whom information on intraoperative transfusion was not available. Basic characteristics of the 4494 patients included in the analysis are presented in Table 1 . Data on long-term survival were available for 3547 patients, of whom 416 were excluded from analyses of long-term outcome, because the observation period was shorter than the previously defined interval of 3 years. Patients with anemia presented less frequently with coronary heart disease, but more often with COPD, diabetes mellitus, peripheral vascular disease, atrial fibrillation, an LVEF <35%, and preoperative renal dysfunction (P < .05 for all) ( Table 1) .
The severity of anemia and other patient characteristics is presented in Table 2 . A total of 1274 patients (28%) presented with mild preoperative anemia, and 346 patients (8%) presented with severe preoperative anemia. Compared with nonanemic patients, the group with mild or severe anemia had a slightly higher median age (P <.001) with a higher percentage of women (P ¼ .003) ( Table 2) . Compared with the mild anemia group, the severe anemia group had more women (P < .001) and more von Heymann et al Perioperative Management
The Journal of Thoracic and Cardiovascular Surgery c Volume -, Number patients who underwent valve surgery (P <.001). Patients with severe anemia had a longer time on CPB (P <.001) and a higher priority of surgery (P < .001). Moreover, severely anemic patients required RBC transfusions more frequently (median, 1 [IQR, 0 to 2] vs 0 [IQR, 0 to 2]; P < .001). In terms of preexisting medical conditions, patients with severe anemia had a lower incidence of coronary artery disease, but higher rates of diabetes mellitus, atrial fibrillation, and preoperative renal dysfunction (P <.05 for all) ( Table 2) .
Outcomes Three-year mortality was 15.0% in nonanemic patients, 30.8% in mildly anemic patients, and 51.2% in severely anemic patients (P <.001). In-hospital survival showed a similar distribution, with mortality rates of 3.7% in nonanemic patients, 8.6% in mildly anemic patients, and 15.0% in severely anemic patients (P<.001). On average, nonanemic patients stayed 4 (IQR, 3 to 7) days in the ICU, compared with 6 (IQR, 4 to 11 days) for mildly anemic patients (P<.001) and 10.5 (IQR, 5 to 25) days for severely anemic patients (P <.001). The median length of hospital stay was 12 (IQR, 8 to 17) days for nonanemic patients, compared with 15 (IQR, 10 to 25) days for mildly anemic patients (P<.001) and 21 (IQR, 13 to 39) days for severely anemic patients (P <.001) ( Table 2) .
In multivariate regression, mild anemia was associated with an HR of 1.44 (95% confidence interval [CI], 1.201 to 1.728; P < .001) and severe anemia was associated with an HR of 1.80 (95% CI, 1.336 to 2.440; P < .001) for long-term survival. Intraoperative transfusion, independent of the occurrence of preoperative anemia, was associated with decreased long-term survival (HR, 1.34; 95% CI, 1.109 to 1.620; P ¼ .002). Furthermore, long-term survival was influenced by age, type of surgery, time on CPB, ACEF score, COPD, coronary artery disease, diabetes mellitus, atrial fibrillation, and peripheral vascular disease (P <.05 for all) ( Table 3) . 
Interaction of Preoperative Anemia Severity and Intraoperative Transfusion
A significant interaction between preoperative anemia and RBC transfusion was found for long-term survival (P <.001) ( Table 4 ). Nonanemic patients who received an RBC transfusion (HR, 2.127; 95% CI, 1.754 to 2.579; P < .001) ( Table 5 ) had approximately the same risk of death during the 3-year observation period as mildly anemic but nontransfused patients (HR, 2.180; 95% CI, 1.802 to 2.638; P <.001) ( Table 5 ). Mildly anemic and transfused patients (HR, 3.057; 95% CI, 2.588 to 3.610; P < .001) had a risk similar to severely anemic patients without transfusion (HR, 3.350; 95% CI, 2.230 to 5.031; P <.001) ( Table 5 ). The highest risk of death during the 3-year observation period was found for severely anemic patients who also required transfusion (HR, 5.098; 95% CI, 4.087 to 6.359; P <.001) ( Table 5 ). Long-term survival of patients depending on anemia and/or transfusion is plotted as Kaplan-Meier curves. (An overall comparison regarding all 6 combinations of anemia and transfusion is provided in Figure 2 ; Kaplan-Meier curves with confidence intervals are shown separately for nontransfused and transfused patients in Figures 3 and 4 , respectively.) von Heymann et al Perioperative Management
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DISCUSSION
The results of our multivariate analysis indicate that the severity of anemia as well as intraoperative transfusion have significant impacts on long-term survival. Regarding the combination of anemia and transfusion, a significant interaction of both factors on survival was seen. Moreover, the outcome effect of severe anemia outweighed that of transfusion. Long-term survival was worse in patients who presented with anemia and received a transfusion compared with those who did not receive a transfusion.
A large body of evidence supports the view that preoperative anemia adversely influences mortality after cardiac surgery. The adverse effect of mild and severe anemia on outcome was recently reported, confirming that severe preoperative anemia (defined as Hb <11 g/dL) was associated with the highest hospital mortality rate. 2 Furthermore, in CABG patients, van Straten et al 3 reported higher early mortality when Hb was 12 to 13 g/dL in men and 11 to 12 g/dL in women, and higher late mortality when Hb was <12 g/dL in men and <11 g/dL in women. 3 For short-term mortality in cardiac surgery, Ranucci et al 23 reported significantly higher intraoperative mortality in patients with severe preoperative anemia (defined as a hematocrit <20%) compared with nonanemic patients. In addition, in patients undergoing aortic valve replacement, an association of the severity of preoperative anemia with mortality has been reported, albeit for late mortality only. 4 Although Scrascia et al 2 used a different definition of severe anemia than ours, their data and our data underscore the fact that the severity of preoperative anemia has a strong impact on mortality after cardiac surgery. For different types of cardiac surgical procedures, all of these studies demonstrate that the more severe the preoperative anemia, the higher the early or late mortality. The authors reported that only transfused anemic patients had a significantly increased hazard of late mortality compared with nonanemic and nontransfused patients. 24 In their definition of anemia, using Hb <12 g/dL in men and <11 g/dL in women, Hb levels are below the WHO's definition of anemia. Although the patients were stratified for ''alive'' and ''died,'' and not for ''anemic/ nonanemic'' or ''transfused/nontransfused,'' their study lacked a nonanemic control group and different severities of preoperative anemia, leaving the impact of anemia and severity of anemia on short-and long-term mortality unclear. 24 In another retrospective analysis of 16,154 patients focusing on major bleeding in cardiac surgery, 13 anemia (but not its severity) and transfusion were identified to enhance the deleterious effects of bleeding on operative mortality. Interestingly, the impact of anemia on operative mortality was highest in nontransfused patients who were not affected by major bleeding, resulting in an increase in mortality from 0.7% to 3.0%. 13 A recent data analysis investigated patients with on-pump hematocrit values <25% and >25% and found that the lower hematocrit group that underwent transfusion during surgery had a long-term survival (median follow-up of 3.7 years) of 67%, compared with 82% in the non-transfused group. 25 The authors concluded that the combined exposure to anemia and RBC transfusion was associated with decreased long-term survival.
It is well known that the severity of preoperative anemia results in a higher transfusion rate. 7 On the other hand, transfusion by itself is associated with increased mortality. 11 It is important to separate effects on outcome, because, for instance, severely anemic patients may be more likely than mildly anemic or nonanemic patients to receive RBC transfusions. Our analysis accounted for this interaction of preoperative anemia and intraoperative transfusion using multivariate analyses. A striking finding of the present study is that whenever preoperative anemia was present, an additional transfusion reduced long-term survival by approximately 50% (for mild anemia: HR, 2180 to 3057; for severe anemia: HR, 3350 to 5098) FIGURE 2. Survival analyses. Long-term survival of patients depending on anemia and/or transfusion are illustrated as Kaplan-Meier curves (P < .001, log-rank test). 95% confidence intervals are shown in Figures 3 and 4 . Pat., Patients. von Heymann et al Perioperative Management
The Journal of Thoracic and Cardiovascular Surgery c Volume -, Number -7 (Table 4) . Moreover, mildly anemic patients who received a transfusion had the same decrease in long-term survival as severely anemic patients who did not receive a transfusion, with approximately 3-fold lower long-term survival. Thus, the co-occurrence of preoperative anemia and intraoperative transfusion is not always associated with the highest risk of mortality. It depends substantially on the severity of anemia; severe anemia by itself has a greater impact on long-term survival than the combination of mild anemia and transfusion. Compared with other risk factors, including age, type of surgery, duration of CPB, ACEF score, COPD, coronary artery disease, diabetes mellitus, atrial fibrillation, peripheral vascular disease, and even transfusion, severe anemia was the strongest risk factor. This seems important to us, because preoperative anemia is treatable, although not necessarily by RBC transfusion only, as opposed to the aforementioned risk factors.
The present analysis has several limitations that are important to acknowledge. First, retrospective analysis is subject to usual investigator bias and to errors in manual data extraction from the medical records. Second, our analysis approach did not differentiate between causes of transfusion (ie, surgical cause of bleeding or anemia treatment). Third, we used logistic regression analysis to widely eliminate confounders of comorbidities. Nevertheless, we cannot rule out all potential chronic diseases or comorbidities that may cause preoperative anemia or worsen the outcome. Fourth, we focused on intraoperative transfusion, because it compensates for preoperative and acute hemodilutional anemia. Postoperative transfusion may be considered necessary for other reasons, such as postoperative bleeding or postoperative bone marrow depression. 26 However, our approach is in line with other reports on preoperative anemia and transfusion 25 and is strictly focused on the interaction of preoperative anemia and its intraoperative treatment. Fifth, possible confounders, such as preoperative treatment of anemia, 27 were not available electronically. However, the treatment of preoperative anemia was not part of standard care during the study period, thus limiting a potential bias of our study.
CONCLUSIONS
Our results suggest that both preoperative anemia and transfusion are by themselves and in combination associated with decreased long-term survival. When anemic patients required transfusion, the risk of death after cardiac surgery may depend to a considerable extent on the severity of preoperative anemia, given that the negative impact of transfusion was multiplied by the underlying severity of preoperative anemia. Finally, the association of preoperative anemia with adverse outcomes may suggest a causal role in cardiac surgery patients. Preoperative anemia could be treated with, for instance, erythropoietin and/or iron in advance to avoid the need for intraoperative transfusion. Intraoperative transfusion to correct preoperative anemia should be handled with caution for this condition.
